Sumatriptan Succinate

Overview

Sumatriptan Succinate is a selective serotonin receptor agonist used primarily in the treatment of migraine attacks. It functions by narrowing blood vessels in the brain, stopping pain signals, and affecting other substances that can trigger migraine symptoms.

API suppliers (8)

Suppliers of Sumatriptan Succinate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
• QUIMICA SINTETICA SASpain1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Natco Pharma Usa1 active DMF
• MOEHS IBERICA SLSpain1 active DMF GMP on record
• SMS Pharmaceuticals limitedIndia GMP on record
• Natco PharmaIndiaCEP GMP on record
• ASYMCHEM LIFE SCIENCE TIANJIN CO LTDChina GMP on record

EU CEP holders (7)

Companies holding a valid EU Certificate of Suitability (CEP) for Sumatriptan Succinate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas